Investment analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Saturday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Price Performance
Ampio Pharmaceuticals stock opened at $0.00 on Friday. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $2.47. The stock has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.02. The company has a market capitalization of $2,964.00, a price-to-earnings ratio of 0.00 and a beta of 3.71.
Ampio Pharmaceuticals Company Profile
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- The Role Economic Reports Play in a Successful Investment Strategy
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Oilfield Leader SLB: An AI Name You Need to Know
- Investing in the High PE Growth Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
